Information Technology Sophistication in Hospitals: A Field Study in Quebec

The Quebec health sector has been experiencing a period of great turmoil over the last five years. Among other institutions, hospitals are faced with huge pressures from government funding cuts. Several empirical studies in the information systems field have shown that the use of computer-based information systems could have positive impacts on organizational performance. Many agree to say that health care institutions are no exceptions. But if one wishes to identify the effects of IT on the delivery of care, one must be able to characterize IT for operationalization purposes. The objective of this research project is twofold. Our first aim consists in developing and validating a measurement instrument of IT sophistication in hospitals. Such instrument should provide hospital managers with a diagnostic tool capable of indicating the profile of their respective institutions in regard to IT use and comparing this profile to those of other similar health institutions. In this line of thought, our second objective consists in presenting the IT sophistication profile of Quebec hospitals. Le secteur de la santé au Québec vit à l'heure des grands bouleversements. Plusieurs s'entendent à dire que les hôpitaux n'ont d'autre alternative que de faire appel aux technologies de pointe afin d'assurer un niveau de qualité des soins adéquat tout en minimisant les coûts associés à ces mêmes soins. Or, si l'on veut identifier les effets de la TI sur la performance des hôpitaux, il faut être capable de définir cette TI en tant que construit et caractériser cette dernière dans un but d'opérationalisation en tant que variable indépendante, dépendante ou modératrice dans un cadre conceptuel de recherche. Cette étude vise deux objectifs particuliers. Le premier consiste à développer un questionnaire mesurant le degré de sophistication des TI en milieu hospitalier et à le valider auprès de la population des hôpitaux québécois. Notre second objectif est de présenter, de façon sommaire, le profil des hôpitaux du Québec en matière de sophistication des TI.IT sophistication, measurement instrument, hospital information systems, Sophistication des TI, instrument de mesure, SI en milieu hospitalier

Wearable continuous vital sign monitoring for deterioration detection and clinical outcomes in hospitalised patients

 Current practice uses physiological early warning scoring (EWS) systems to monitor “standard” vital signs, including heart rate (HR), respiratory rate (RR), blood pressure (BP), oxygen saturations (SpO2) and temperature, coupled with a graded response such as referral for a senior review or increasing monitoring frequency. Early detection of the deteriorating patient is a known challenge within hospital environments, as EWS is dependent on correct frequency of physiological observations tailored to specific patient needs, that can be time consuming for healthcare professionals, resulting in missed or incomplete observations. Wearable monitoring systems (WMS) may bring the potential to fill the gap in vital sign monitoring between traditional intermittent manual measurements and continuous automatic monitoring. However, evidence on the feasibility and impact of WMS implementation remains scarce. The virtual High Dependency Unit (vHDU) project was designed to develop and test the feasibility of deploying a WMS system in the hospital ward environment. This doctoral work aims to critically analyse the roadmap work of the vHDU project, containing ten publications distributed throughout 7 chapters. Chapter 1 (with 3 publications) includes a systematic review and meta-analysis identifying the lack of statistical evidence of the impact of WMS in early deterioration detection and associated clinical outcomes, highlighting the need for high-quality randomised controlled trials (RCTs). It also supports the use of WMS as a complement, and not a substitute, for standard and direct care. Chapter 2 explores clinical staff and patient perceptions of current vital sign monitoring practices, as well as their early thoughts on the use of WMS in the hospital environment through a qualitative interview study. WMS were seen positively by both clinical and patient groups as a potential tool to bridge the gap between manual observations and the traditional wired continuous automatic systems, as long as it does not add more noise to the wards nor replaces direct contact from the clinical staff. In chapter 3, the wearability of 7 commercially available wearables (monitoring HR, RR and SpO2) was assessed, advocating for the use of pulse oximeters without a fingertip probe and a small chest patch to improve worn times from the patients. Out of these, five devices were submitted to measurement accuracy testing (chapter 4, with 3 publications) under movement and controlled hypoxaemia, resulting in the validation of a chest patch (monitoring HR and RR) and proving the diagnostic accuracy of 3 pulse oximeters (monitoring pulse rate, PR and SpO2) under test. These results were timely for the final selection of the devices to be integrated in our WMS, namely vHDU system, explored in chapter 5, outlining the process for its development and rapid deployment in COVID-19 isolation wards in our local hospital during the pandemic. This work is now converging in the design of a feasibility RCT to test the impact of the vHDU system (now augmented with blood pressure and temperature monitoring, completing all 5 vital signs) versus standard care in an unbiased environment (chapter 6). This will also ascertain the feasibility for a multicentre RCT, that may in the future, contribute with the much-needed statistical evidence to my systematic review and meta-analysis research question, highlighted in chapter 1. Finally, chapter 7 includes a critical reflection of the vHDU project and overall doctoral work, as well as its contributions to the field of wearable monitoring.<p class="MsoNormal"/

The Geriatric Patient: The Ideal One for Chest Ultrasonography? A Review From the Chest Ultrasound in the Elderly Study Group (GRETA) of the Italian Society of Gerontology and Geriatrics (SIGG)

OBJECTIVES: To investigate the current evidence on the use of point-of-care chest ultrasonography in older patients and geriatric settings and present the current state of the art of chest ultrasound applications. DESIGN: Special article based on a literature review with narrative analyses and expert clinical knowledge. SETTING AND PARTICIPANTS: All studies performed in a geriatric setting were included. Observational and intervention studies and meta-analyses including participants aged ≥70 years were also considered, even if not specifically focused on a geriatric setting. MEASURES: Data on participant characteristics, diagnostic accuracy of chest ultrasonography, and outcomes were collected for each considered study. Data were analyzed and discussed with a particular focus on the possible applications and advantages of chest ultrasonography in geriatric medicine, underlining the possible areas of future research. RESULTS: We found only 5 studies on the diagnostic accuracy and prognostic relevance of chest ultrasonography in geriatrics. However, several studies performed in emergency departments, intensive care units, and internal medicine wards included a large number of participants ≥70 years old; they suggest that chest ultrasonography may represent a valid aid to the diagnostics of acute dyspnea, pneumonia, acute heart failure, pneumothorax, and pleural diseases, with an accuracy in some cases superior to standard x-rays, especially when mobility limitation is present. Diaphragm ultrasonography may also represent a valid tool to guide mechanical ventilation weaning in older patients with acute respiratory failure. CONCLUSIONS AND IMPLICATIONS: Chest ultrasonography may represent a valid bedside diagnostic aid to the management of acute respiratory diseases in older patients. However, specific evidence is lacking for geriatric patients. Future research will need to focus on defining the reference standards and the diagnostic accuracy for older patients with frailty and multimorbidity, cost-efficacy and cost-effectiveness of the technique, its impact for clinical outcomes, and role for follow-up in the post-acute care

Genetic Variation of the Human α-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV Infection

Genetic background may play an important role in the process of SARS-CoV infection and SARS development. We found several proteins that could interact with the nucleocapsid protein of the SARS coronavirus (SARS-CoV). α-2-Heremans-Schmid Glycoprotein (AHSG), which is required for macrophage deactivation by endogenous cations, is associated with inflammatory regulation. Cytochrome P450 Family 3A (CYP4F3A) is an ω-oxidase that inactivates Leukotriene B4 (LTB4) in human neutrophils and the liver. We investigated the association between the polymorphisms of these two inflammation-associated genes and SARS development. The linkage disequilibrium (LD) maps of these two genes were built with Haploview using data on CHB+JPT (version 2) from the HapMap. A total of ten tag SNPs were selected and genotyped. In the Guangzhou cohort study, after adjusting for age and sex, two AHSG SNPs and one CYP4F3 SNP were found to be associated with SARS susceptibility: rs2248690 (adjusted odds ratio [AOR] 2.42; 95% confidence interval [CI] 1.30-4.51); rs4917 (AOR 1.84; 95% CI 1.02-3.34); and rs3794987 (AOR 2.01; 95% CI 1.10–3.68). To further validate the association, the ten tag SNPs were genotyped in the Beijing cohort. After adjusting for age and sex, only rs2248690 (AOR, 1.63; 95% CI, 1.30–2.04) was found to be associated with SARS susceptibility. The combined analysis of the two studies confirmed tag SNP rs2248690 in AHSG as a susceptibility variant (AOR 1.70; 95% CI 1.37–2.09). The statistical analysis of the rs2248690 genotype data among the patients and healthy controls in the HCW cohort, who were all similarly exposed to the SARS virus, also supported the findings. Further, the SNP rs2248690 affected the transcriptional activity of the AHSG promoter and thus regulated the AHSG serum level. Therefore, our study has demonstrated that the AA genotype of rs2268690, which leads to a higher AHSG serum concentration, was significantly associated with protection against SARS development

How do muscle and bone strengthening and balance activities (MBSBA) vary across the life course, and are there particular ages where MBSBA are most important?

This narrative review focuses on the role of strength and balance activities throughout the lifecycle to improve physical capacity and reduce all-cause mortality. The evidence suggests strong associations in middle and older age, with poor balance, poor strength or poor physical function having strong associations with mortality. Currently in the UK, the proportions of adults (69% of men and 76% of women) not meeting the strength and balance guidelines (of 2 or more sessions/week) is concerning. This report identifies specific time points in the lifecycle where specific promotion of and engagement with strength and balance activities would be most beneficial for health: 18-24y to maximize bone and muscle mass gains, 40-50y to maintain strength and reduce that downward cycle, and over 65s to preserve balance and strength and maintain independence). This review also suggests specific transition points/events in life where there may be an increase in sedentary behaviour or loss of muscle function (pregnancy, menopause, onset of on diagnosis of disease, retirement, on becoming a carer and following hospitalization), where it would be useful to initiate additional strength and balance exercises to improve future health outcomes

Hospitalization at home: a study of international models and adaptation to the portuguese context

Hospitalization at Home (HaH) has proved to be an efficient and effective model of healthcare provision in several countries in the World. Portugal is starting the implementation of this model based on international best-practices. This paper describes themain features of this HaH service, their organizational, technological and economic enablers –with a sustainability perspective. It then presents their application in recognized role-model countries –the UK, Australia, and Spain. Finally, it outlines the current implementation plan being carried out by the Portuguese Public National Healthcare Service and aims to identify opportunities for improvements in such implementation

Prediction and monitoring of in-hospital cardiac arrest

Background: In-hospital cardiac arrest (IHCA) is a global health concern of major importance, associated with a poor prognosis. IHCA is frequently heralded by a deterioration of vital signs, and many cases are considered preventable. Hence, prevention has become a key strategy. The overall aim of this thesis was to study the prevention of IHCA, by means of prediction and monitoring, with a view to improve patient safety. Methods: Study I and III are observational cohort studies, based on the Swedish Registry of Cardiopulmonary Resuscitation (SRCR). In study III, we also collected additional data from medical records in a small, hypothesis-generating group of patients. Study II and IV are prospective, observational cohort studies based on patients reviewed by Rapid Response Teams (RRTs) in 26 and 24 Swedish hospitals, respectively. In study IV, additional data on long-term survival was obtained from either medical records or the personal information directory, containing population registration data. Specific study aims and results: In study I, we investigated how 30-day survival after IHCA was influenced by ECG monitoring at the time of collapse, as well as clinical factors that determined whether patients were ECG monitored adjacent to cardiac arrest (CA). In all, 24,790 patients were enrolled in the SRCR between 2008 and 2017. After applying the exclusion criteria, 19,225 patients remained, of which 52% were monitored at the time of collapse. In all, 30-day survival was 30%. ECG monitoring at the time of CA was associated with a Hazard Ratio of 0.62 (95% Confidence Interval 0.60-0.64) for 30-day mortality. The strongest predictor of ECG monitoring adjacent to IHCA was location in hospital. There were tangible variations in the frequency of patients who were ECG monitored at the time of collapse between Swedish regions and across hospitals. In study II, we investigated the predictive power of NEWS 2, as compared to NEWS, in identifying patients at risk of Serious Adverse Events (SAEs) within 24 hours of an RRT-review. In all, 1,065 patients, reviewed by RRTs in general wards during the study period between October 2019 and January 2020, were included. After applying the exclusion criteria, 898 patients were eligible for complete case analyses. In all, 37% of the patients were admitted to the Intensive care unit (ICU) within 24 hours of RRT-review. In-hospital mortality and IHCA were uncommon (6% and 1% respectively). The Area Under the Receiver Operating Characteristic (AUROC) for both NEWS and NEWS 2 was 0.62 for the composite outcome, and 0.69/0.67 for mortality. Regarding the outcome unanticipated ICU admission, the AUROC was 0.59 and 0.60, respectively, while the AUROC for IHCA was 0.51 (NEWS) and 0.47 (NEWS 2), respectively. In study III, we investigated 30-day survival and ROSC in patients suffering from IHCA, who were reviewed by an RRT within 24 hours prior to the CA, as compared to those without such review. Furthermore, we studied patient centred factors prior to RRT activation, the timeliness of the RRT-review as well as the reason for the RRT-review. We also investigated the association between RRT interventions and outcome. During the study period between 2014 and 2021, 19,973 patents were enrolled in the SRCR. After applying the exclusion criteria, 12,915 patients remained. Among these IHCA patients, there was an RRT/ICU contact within 24 hours prior to the CA in 2,058 cases (19%). The adjusted 30-day survival was lower among patients reviewed by an RRT prior to IHCA (25% vs. 33%, p <0.001). Regarding ROSC, we did not observe any difference between the groups. The propensity score based Odds Ratio for 30- day survival was 0.92 for patients who were reviewed by an RRT (95% CI 0.90 to 0.94, p <0.001), as compared to those who were not RRT- reviewed within 24 hours prior to IHCA. A respiratory cause of CA was more common among IHCA patients who were reviewed by an RRT. In the small, explorative subgroup (n=82), 24% of the RRT activations were delayed, and respiratory distress was the most common RRT trigger. We observed a significantly lower 30-day survival among patients triaged to remain at ward compared to those triaged to a higher level of care (2% vs. 20%, p 0.016). In study IV, we explored the impact of age on the ability of NEWS 2 to predict IHCA, unanticipated ICU-admission, or death, and the composite of these three SAEs, within 24 hours of review by an RRT. Furthermore, we aimed to investigate 30-, 90- and 180-day mortality, and the discriminative ability of NEWS 2 in the prediction of long-term mortality among RRT-reviewed patients. In this multi-centre study based on data prospectively collected by RRTs, the NEWS 2 scores of all patients were retrospectively, digitally calculated by the study team. Age was analysed as a continuous variable, in a spline regression model, and categorized into five different models, subsequently explored as additive variables to NEWS 2. The discriminative ability of NEWS 2 in predicting 30-day mortality improved by adding age as a covariate (from AUROC 0.66, 0.62-0.70 to 0.70, 0.65-0.73, p=0.01). There were differences across age groups, with the best predictive performance identified among patients aged 45-54 years. The 30-, 90-and 180-day mortality was 31%, 33%, and 36%, respectively. Conclusion: ECG monitoring at the time of IHCA was associated with a 38% reduction of adjusted mortality. Despite this finding, only one in two IHCA patients were ECG monitored. The most important factor influencing ECG monitoring was which type of hospital ward the patient was admitted to. The tangible variations in the frequency of ECG monitoring adjacent to IHCA observed between Swedish regions and across hospitals need to be investigated in future studies. Guidelines for the monitoring of patients at risk of CA could contribute to an improved outcome. The prognostic accuracy of NEWS 2 in predicting mortality within 24 hours of an RRT-review was acceptable, whereas the discriminative ability in prediction of unanticipated ICU-admission and the composite outcome was rather weak. Regarding the prediction of IHCA, NEWS 2 performed poorly. There was no difference in the prognostic accuracy between NEWS and NEWS 2; however, the discriminative ability was not considered sufficient to serve as a triage tool in RRT-reviewed patients. In-hospital cardiac arrest among patients who were reviewed by an RRT prior to CA was associated with a poorer prognosis, and a more frequent respiratory aetiology of the CA. In the explorative sub-group of patients, RRT activation was frequently delayed, the most common trigger for RRT-review was respiratory distress, and escalation of the level of care was associated with an improved prognosis. Early identification of patients with abnormal respiratory vital signs, followed by a timely response, may have a potential to improve the prognosis for patients reviewed by an RRT and prevent IHCA. Adding age as a covariate improved the discriminative ability of NEWS 2 in the prediction of 30-day mortality among RRT-reviewed patients. The ability differed across age categories. Overall, the long-term prognosis of RRT-reviewed patients was poor. Our results indicate that age merits further validation as a covariate to improve the performance of NEWS 2

Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection

Peste des petits ruminants (PPR) disease was first confirmed in Tanzania in 2008 in sheep and goats in Ngorongoro District, northern Tanzania, and is now endemic in this area. This study aimed to characterise PPR disease in pastoralist small ruminant flocks in Ngorongoro District. During June 2015, 33 PPR-like disease reports were investigated in different parts of the district, using semi-structured interviews, clinical examinations, PPR virus rapid detection test (PPRV-RDT), and laboratory analysis. Ten flocks were confirmed as PPRV infected by PPRV-RDT and/or real-time reverse transcription-polymerase chain reaction (RT-qPCR), and two flocks were co-infected with bluetongue virus (BTV), confirmed by RT-qPCR. Phylogenetic analysis of six partial N gene sequences showed that the PPR viruses clustered with recent lineage III Tanzanian viruses, and grouped with Ugandan, Kenyan and Democratic Republic of Congo isolates. No PPR-like disease was reported in wildlife. There was considerable variation in clinical syndromes between flocks: some showed a full range of PPR signs, while others were predominantly respiratory, diarrhoea, or oro-nasal syndromes, which were associated with different local disease names (olodua—a term for rinderpest, olkipiei—lung disease, oloirobi—fever, enkorotik—diarrhoea). BTV co-infection was associated with severe oro-nasal lesions. This clinical variability makes the field diagnosis of PPR challenging, highlighting the importance of access to pen-side antigen tests and multiplex assays to support improved surveillance and targeting of control activities for PPR eradication